| Trial ID | NCT07271030 |
| Status | Recruiting |
| Condition | Well-Being, Psychological |
| Intervention | Cannabidiol suppository intervention 1 |
Sexual pain disorders affect up to 20% of women and significantly impact quality of life, yet treatment options remain limited. This trial addresses a critical gap by investigating topical cannabidiol delivery for vulvodynia and dyspareunia, conditions where systemic medications often provide inadequate relief.
This randomized controlled trial is evaluating dose-specific cannabidiol suppositories for sexual pain reduction over one month with 12-week follow-up. The study employs both quantitative pain measures and qualitative patient feedback to assess impact on sexual function, well-being, and quality of life. Currently recruiting participants, this appears to be an early-phase investigation with plans for larger-scale replication if results prove promising.
“If positive, this trial could establish cannabidiol suppositories as a targeted, non-systemic option for sexual pain disorders where current treatments often fall short. The localized delivery approach may offer therapeutic benefits while minimizing systemic cannabinoid exposure.”
💬 Join the Conversation
Have a question about how this applies to your situation? Ask Dr. Caplan →
Want to discuss this topic with other patients and caregivers? Join the forum discussion →
Have thoughts on this? Share it:
FAQ
What is the cannabidiol suppository trial for sexual pain testing?
It is a randomized controlled trial, registered as NCT07271030, evaluating dose-specific cannabidiol suppositories for reducing sexual pain. The intervention period is one month, and the study includes a 12-week follow-up period.
How will researchers measure whether CBD suppositories help sexual pain?
The trial uses both quantitative pain measures and qualitative feedback from patients. Together, these are meant to assess how the suppositories affect sexual function, well-being, and quality of life, in addition to pain.
Is the CBD suppository trial still enrolling, and are results available?
The trial is currently recruiting participants, so results have not yet been reported. It appears to be an early-phase investigation, and larger-scale replication is planned if the results prove promising.
Get the next evidence review in your inbox
Plain-language summaries of the newest cannabis research, written by a physician. Free to read, and you can unsubscribe at any time.
Join the growing cannabis community. Free. One-click subscribe. Delivered by Substack.
